Table 2.

Challenges of the kidney transplant program

Variable	Frequency (percent)
Availability of immunosuppressive drugs
Induction immunosuppressive drugs	100%
Maintenance immunosuppressive drugs	100%
Supply chain of immunosuppressive
Sourced from outside the country	100%
Histocompatibility tests  HLA, CDC, DSA and PRA Outsourced to other laboratory Donor availability for 103 recipients	100%
Recipients with donors who met criteria	55(53%)
Recipients with unfit donors	37(36%)
Recipients with no donors	11(11%)
Sponsorship of kidney transplant procedure
Employer	14(38%
Self	11(30%)
Government	12 (32%)
Sponsorship of maintenance immunosuppressive drugs
National Health insurance fund	33(90%)
Self	2(5%)
Employer	2(5%)